Yüklüyor......
Effects of vildagliptin as add-on treatment in patients with type 2 diabetes mellitus: insights from long-term clinical studies in Japan
BACKGROUND: Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is wildly used to treat type 2 diabetes mellitus (T2DM) with mono- or combination-therapy. We review two previously published open-label studies to extract insights on the long-term efficacy and safety of vildagliptin. METHODS: Tw...
Kaydedildi:
| Yayımlandı: | J Diabetes Metab Disord |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4932694/ https://ncbi.nlm.nih.gov/pubmed/27382546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40200-016-0240-z |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|